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Abstract
Lck and Fyn, members of the Src family of tyrosine kinases, are key components of the abTCR-coupled signaling pathway.
While it is generally accepted that both Lck and Fyn positively regulate signal transduction by the abTCR, recent studies
have shown that Lck and Fyn have distinct functions in this signaling pathway, with Lck being a positive regulator and Fyn
being a negative regulator of abTCR signal transduction. To determine whether Lck and Fyn also differentially regulate
cdTCR signal transduction, we analyzed cd T cell development and function in mice with reduced Lck or Fyn expression
levels. We found that reducing Lck or Fyn levels altered the strength of the cdTCR signaling response, with low levels of Lck
weakening cdTCR signal strength and low levels of Fyn augmenting cdTCR signal strength. These alterations in cdTCR signal
strength had profound effects not only on ab/cd lineage choice, but also on cd thymocyte maturation and cd T cell effector
function. These results indicate that the cellular levels of Lck and Fyn play a role in regulating the strength of the cdTCR
signaling response at different stages in the life of the cd T cell.
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Introduction
Signaling by the TCR is required at multiple stages in the life
of a T cell. In the thymus, TCR signaling is necessary for lineage
commitment and repertoire selection, while in the periphery,
TCR signaling is necessary for maintenance of the peripheral T
cell pool and for activation and differentiation of mature T cells.
Lck and Fyn, two members of the Src family of tyrosine kinases
(SFKs), are involved in initiating the TCR-coupled signaling
cascade [1,2]. Following TCR engagement, Lck and/or Fyn
phosphorylate the tyrosines within the ITAMs of the CD3 and
TCRf chains. This proximal signaling event leads to the
recruitment of other signaling molecules to the TCR signaling
complex and to the subsequent activation of signaling pathways
that ultimately lead to the nucleus and initiation of gene
transcription.
It is generally accepted that both Lck and Fyn positively
regulate signal transduction by the abTCR because, in the
absence of either one of these SFKs, abTCR signaling responses
are impaired following anti-CD3 mAb stimulation [3–9]. Howev-
er, it has also been shown that Lck and Fyn localize to different
subcellular compartments [10,11] and have different substrates
[11,12], suggesting that they have discrete functions during ab T
cell activation. This idea is supported by the disparate phenotypes
of Lck- and Fyn-deficient mice. In Lck
2/2 mice, thymus
cellularity is severely reduced, thymocyte development is almost
completely blocked at the CD4
+CD8
+ (double-positive; DP) stage,
and very few mature abTCR
+ cells are detected in peripheral
lymphoid tissues [12–14]. In contrast, Fyn
2/2 mice exhibit a mild
defect in ab T cell development, as shown by the fact that Fyn
2/2
thymocytes, when in vitro stimulated, do not flux calcium or
proliferate as well as wild-type (WT) thymocytes [3,5]. Despite this
signaling defect in the thymus, equivalent numbers of ab T cells
are found in the periphery of Fyn
2/2 and WT mice [3,5].
While recent studies have confirmed that Lck functions
primarily as a positive regulator of abTCR signaling [15–17],
evidence is accumulating in support of Fyn acting as a negative
regulator of abTCR signaling. First, it has been shown that Fyn is
responsible for phosphorylating the adaptor protein, phosphopro-
tein associated with glycolipid-enriched membranes or PAG, in
both resting thymocytes and T cells [11]. Once phosphorylated,
PAG then recruits Csk, an inhibitor of SFKs [18]. Recruitment of
Csk to phosphorylated PAG is required for optimal Csk kinase
activity because, in the absence of Fyn, there is reduced
phosphorylation of PAG and reduced Csk kinase activity [11].
Therefore, by indirectly controlling the activity of the inhibitor
Csk, Fyn may negatively regulate the activation threshold of ab T
cells [11]. It has also been shown that CD8
+ T cells from Fyn
2/2
F5 abTCR Tg mice are hyperresponsive in comparison to CD8
+
T cells from WT F5 abTCR Tg mice following in vitro stimulation
with peptide and APCs [19]. This hyperresponsiveness is
manifested as enhanced proliferation, increased IL-2 production
and more effective cytolytic activity [19]. CD4
+ T cells from
Fyn
2/2 DO11.10 abTCR Tg mice, however, do not display
increased proliferation compared to CD4
+ T cells from WT
DO11.10 abTCR Tg mice when stimulated, either in vitro or in
vivo, with peptide and APCs [20]. Nonetheless, when activated
under the appropriate priming conditions, CD4
+ T cells from
Fyn
2/2 DO11.10 abTCR Tg mice produce significantly more IL-
4 or IFNc than CD4
+ T cells from WT DO11.10 abTCR Tg mice
PLoS ONE | www.plosone.org 1 January 2010 | Volume 5 | Issue 1 | e8899[20]. Taken together, these findings suggest that Fyn negatively
regulates the abTCR signaling response.
Since studies investigating the functions of Lck and Fyn have
focused primarily on ab T cells, it is not known whether their
functional dichotomy is observed in only ab T lineage cells or in




2/2 mice have in fact revealed differences in the requirements
for these SFKs in ab and cd T cell development. In Lck
2/2 mice,
the number of thymic and peripheral cd T cells is only modestly
reduced compared to their numbers in WT mice [13,14,21].
Moreover, in Lck
2/2 Fyn
2/2 mice, in which ab T cell develop-
ment is completely abrogated, a small number of cdTCR
+ cells do
develop and can be detected in secondary lymphoid tissues, the
small intestine, and the epidermis [21,22]. These differential
requirements for Lck and Fyn in ab and cd T cell development
suggest that these SFKs may have different functions in ab- and
cdTCR signal transduction. To investigate this, we evaluated the
individual roles of Lck and Fyn in the development and function of
cd lineage cells. Here, we report that Lck and Fyn expression
levels vary in cd lineage cells depending on their stage in
development, with thymic cd T cells expressing relatively high
levels of Lck and Fyn and peripheral cd T cells expressing
relatively low levels of Lck and Fyn. These differences in the
cellular levels of Lck and Fyn play a role in regulating the strength
of the cdTCR signaling response at the different developmental
stages because, when we reduced Lck or Fyn expression levels by
using Lck
+/2 and Fyn
+/2 mice, we observed significant effects on
ab/cd lineage choice, cd thymocyte maturation, and cd T cell
effector function. Moreover, because reducing the levels of Lck or
Fyn altered the cdTCR signaling response, such that low Lck
levels weakened cdTCR signal strength and low Fyn levels
augmented cdTCR signal strength, we conclude that Lck and Fyn
have similar functions in ab- and cdTCR signal transduction, with
Lck serving to amplify the TCR signal and Fyn serving to dampen
the TCR signal.
Results
Expression Pattern of Lck and Fyn in cd Lineage Cells
Although it is generally accepted that cd T cells express Lck and
Fyn, this idea is based more on indirect evidence from studies
investigating cd T cell development in Lck- or Fyn-deficient mice
[13,14,21,23,24] than on a direct demonstration of expression
[25]. To resolve this, we developed an intracellular (i.c.) flow
cytometric assay to measure and compare the relative levels of Lck
and Fyn in ab and cd lineage cells from wild-type (WT) mice.
Using Lck
2/2 and Fyn
2/2 cells as negative staining controls, we
found that both Lck and Fyn are expressed in DN cd thymocytes
and peripheral DN cd T cells (Fig. 1A). On average, DN cd
thymocytes expressed Lck and Fyn at higher levels than DP and
mature CD4
+ thymocytes, whereas peripheral DN cd T cells
expressed Lck at levels comparable to those in CD4
+ T cells and
Fyn at levels lower than those in CD4
+ T cells (Fig. 1A). When Lck
and Fyn expression levels were compared between thymic and
peripheral cd T cells, we found that both SFKs are expressed at
significantly higher levels in DN cd thymocytes than in DN cd T
cells (Fig. 1B–C). This finding suggested that the expression levels
of both Lck and Fyn are down-regulated once cd T cells emigrate
from the thymus to the secondary lymphoid organs. This same
phenomenon was also observed for ab lineage cells; however, the
degree of reduction in Lck and Fyn expression levels between the
thymus and LN was greater for cd lineage cells than ab lineage
cells (Fig. 1C and data not shown). Taken together, these data
indicated that immature and mature cd lineage cells express Lck
and Fyn and that the expression of these SFKs is dynamic during
cd T cell development and maturation.




Because DN cd thymocytes expressed higher levels of Lck and
Fyn than mature DN cd T cells, we sought to determine whether
high levels of Lck or Fyn were required for cd lineage commitment
and/or development in the thymus. To investigate this, we
reduced the expression levels of Lck or Fyn during T cell
development by using Lck
+/2 and Fyn
+/2 mice. To verify that
protein expression was reduced in the heterozygous mice, we
compared the relative expression levels of Lck and Fyn in
immature and mature CD4
+ lineage cells from Lck
+/2 and
Fyn
+/2 mice with those from WT mice. As expected, we observed a
50% reduction in Lck expression levels in Lck
+/2 mice and a 50%
reduction in Fyn expression levels in Fyn
+/2 mice (Fig. 2A). In
addition, there was no compensatory increase in the expression of
one SFK when expression of the other SFK was reduced (Fig. 2A).
When cd T cell development was analyzed in Lck
+/2 and
Fyn
+/2 mice, we observed no significant difference in the number
of DN cd TCR
+ cells in the thymus and lymph nodes (LNs) of
these mice compared to WT mice (Fig. 2B). Moreover, phenotypic
analysis of the DN cd thymocytes and mature DN cd T cells from
WT, Lck
+/2 and Fyn
+/2 mice revealed no appreciable differences
in Vc usage, TCRcd surface levels and cell surface phenotype
(data not shown), indicating that reducing the expression levels of
Lck or Fyn resulted in no apparent defect in the development of
polyclonal cd T cells.
Because cd T cell development appeared not to be affected in
Lck
+/2 and Fyn
+/2 mice, we examined the levels of Lck and Fyn
in cd lineage cells of the heterozygous mice to determine whether
they were reduced by 50% as they were in ab lineage cells (Fig. 2A
and C). We found that Lck levels were indeed reduced by 50% in
thymic and peripheral cd lineage cells from Lck
+/2 mice (Fig. 2C).
Fyn levels, on the other hand, were reduced to ,60% in immature
and mature cd lineage cells from Fyn
+/2 mice, which is
significantly different from the expected 50% (Fig. 2C). Since
Fyn expression levels in cd lineage cells were not reduced to the
expected 50% in Fyn
+/2 mice, we determined whether the thymic
precursors in Lck
+/2 and Fyn
+/2 mice displayed a 50% reduction
in Lck and Fyn expression levels, respectively. To accomplish this,
we compared Lck and Fyn expression levels in lineage-negative
CD44
+CD25
+ (DN2) thymocytes from WT, Lck
+/2 and Fyn
+/2
mice, as this thymocyte subset contains precursors that have the
potential to develop into ab or cd lineage cells [26,27]. We found
that, while Lck expression levels were reduced to 50% in Lck
+/2
DN2 thymocytes, Fyn expression levels were only reduced to
85% in Fyn
+/2 DN2 thymocytes (Fig. 2D and E). These data
demonstrated that although Fyn levels are reduced in thymic
precursors and cd lineage cells from Fyn
+/2 mice, they are not
reduced by 50% as they are in ab lineage cells.
Effect of Reducing Lck or Fyn Levels on the Commitment
and Development of cd Lineage Cells
Another reason why we may not have observed any defects in
cd T cell development in Lck
+/2 and Fyn
+/2 mice is because
thymocyte development and selection are able to compensate for
alterations in cdTCR signal transduction, which may result from
reductions in Lck or Fyn expression. To address this, we mated a
cdTCR transgene onto Lck
+/2 and Fyn
+/2 genetic backgrounds
to determine whether fixing the specificity of the cdTCR revealed
defects in ab/cd lineage choice and/or cd T cell development. For
Lck, Fyn and cdTCR Signaling
PLoS ONE | www.plosone.org 2 January 2010 | Volume 5 | Issue 1 | e8899Figure 1. Flow cytometric analysis of the intracellular levels of Lck and Fyn in cd lineage cells. A. Histograms show representative staining
of the i.c. levels of Lck and Fyn in gated populations of DP thymocytes and of thymic and LN CD4
+ CD3
+ and DN cdTCR
+ cells from WT (B6) mice.
Staining of cells from Lck
2/2 and Fyn
2/2 mice are shown as negative controls for i.c. staining of Lck and Fyn, respectively. B. Comparison of the
relative expression levels of Lck and Fyn in gated DN cdTCR
+ thymocytes and LN cells. C. Quantifying the change in the relative expression levels of
Lck and Fyn in DN cdTCR
+ thymocytes and LN cells and, for comparison, CD4
+ CD3
+ thymocytes and LN cells. Lck and Fyn expression levels in
immature and mature subsets were normalized to those of DP thymocytes, as this population had, in every experiment, consistently lower levels of
Lck and Fyn than any other thymocyte or T cell subset (see A). Data are presented as fold change relative to DP thymocytes (set to 1). Data are
representative of at least 6 independent experiments. Bars represent mean 6 SEM. *p#0.05,* * p#0.01, #p#0.001.
doi:10.1371/journal.pone.0008899.g001
Lck, Fyn and cdTCR Signaling
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Jd2/Cd transgenic (cdTCR Tg) mouse [28], which we have
previously used to study ab/cd lineage choice, cd T cell
development and cdTCR signal transduction [29–31]. It is
important to note that, although Vc6/Vd1
+ cd T cells are only
generated in the fetal thymus of a WT (non-cdTCR Tg) mouse
[28], the Vc6/Vd1
+ cd T cells generated in the cdTCR Tg mouse
represent adult cd T cells, as they express the panel of cd-biased
genes [31] typical of adult but not fetal cd T cell populations [32].
Moreover, one of the advantages of using this cdTCR Tg mouse
model to study ab/cd lineage choice is that the rearranged TCRc
and –d chains are expressed early during T cell development prior
to TCRb expression and, as a consequence, the ab/cd lineage
decision is mediated exclusively by the cdTCR [29].
By fixing the specificity of the cdTCR, we observed significant
effects on the ab/cd lineage fate decision when the levels of Lck
but not Fyn were reduced. In WT cdTCR Tg mice, equivalent
numbers of DN cdTCR
+ thymocytes (cd lineage) and DP
thymocytes (ab lineage cells) are generated (Fig. 3A–B). Reducing
Lck expression resulted in a striking 4-fold increase in thymus cell
number compared to WT cdTCR Tg mice, most likely due to the
significant increase in the percentage of DP thymocytes (Fig. 3A).
Consequently, the number of ab lineage cells in Lck
+/2 cdTCR
Tg mice was significantly higher than that in WT cdTCR Tg mice
(Fig. 3B). These findings are consistent with those of a previous
study, in which cdTCR-dependent generation of DP thymocytes
but not of DN cdTCR
+ thymocytes was observed in the absence of
Lck expression [33]. In contrast, reducing Fyn levels had no effect
on total thymus cell number. Nonetheless, we did observe a
decrease in both the percentage and number of DP thymocytes in
Fyn
+/2 cdTCR Tg mice, although these differences were not
statistically significant from the percentage and number of DP
Figure 2. Effect of reducing Lck or Fyn levels on polyclonal cd T cell development. A. Demonstration of the reduction of Lck or Fyn levels in
CD4
+ thymocytes and LN cells from Lck
+/2 and Fyn
+/2 mice. The MFI of the i.c. levels of Lck and Fyn in CD4
+ lineage cells from heterozygous mice are
expressed as a percentage of the MFI of the i.c. levels of Lck and Fyn in CD4
+ lineage cells from WT mice. A dashed line marks the expected 50%
reduction in WT Lck and Fyn levels. B. Number of DN cd thymocytes and LN cd T cells in WT, Lck
+/2, and Fyn
+/2 mice. Data represent at least 6 mice
per genotype. C. Quantifying the reduction of Lck and Fyn expression levels in DN cdTCR
+ thymocytes and LN cells from Lck
+/2 and Fyn
+/2 mice. The
MFI of the i.c. levels of Lck and Fyn in cd lineage cells from heterozygous mice are expressed as a percentage of the MFI of the i.c. levels of Lck and
Fyn in cd lineage cells from WT mice. A dashed line marks the expected 50% reduction in WT Lck and Fyn levels. D. Relative expression levels of Lck
and Fyn in WT DN2 (lin
2 CD25
+ CD44
+) thymocytes, where lin










E. Quantifying the reduction of Lck and Fyn expression levels in DN2 thymocytes from Lck
+/2 and Fyn
+/2 mice. The MFI of the i.c. levels of Lck and Fyn
in DN2 thymocytes from heterozygous mice are expressed as a percentage of the MFI of the i.c. levels of Lck and Fyn in DN2 thymocytes from WT
mice. A dashed line marks the expected 50% reduction in WT Lck and Fyn levels. In A, B, C, and E, the bars represent mean 6 SEM. *p#0.05,* * p#0.01,
#p#0.001.
doi:10.1371/journal.pone.0008899.g002
Lck, Fyn and cdTCR Signaling
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despite the changes in the numbers of DP thymocytes in the
heterozygous mice, the numbers of DN cdTCR
+ thymocytes, or
cd lineage cells, in Lck
+/2 cdTCR Tg and Fyn
+/2 cdTCR Tg
mice were comparable to their number in WT cdTCR Tg mice
(Fig. 3A–B).
It has previously been shown that genetic manipulation of
cdTCR signal strength affects ab/cd lineage choice in a
consistent manner. Namely, when the cdTCR signaling response
is strengthened, cd lineage fate is favored and, conversely, when
the cdTCR signaling response is weakened, ab lineage fate is
favored [29,33]. Our finding that the number of ab lineage cells
was significantly increased in Lck
+/2 cdTCR Tg mice compared
to WT cdTCR Tg mice suggested that reducing Lck levels
weakened cdTCR signal strength. Surprisingly, this increase in
the number of DP thymocytes was not accompanied by a
corresponding decrease in the number of DN cd thymocytes in
Lck
+/2 cdTCR Tg (Fig. 3B). We reasoned that the number of
DN cd thymocytes in Lck
+/2 cdTCR Tg mice may not reflect
the number of thymocytes that adopted the cd fate but instead
reflected an expansion of the thymocytes that already adopted
the cd fate. To investigate this, we compared the proliferative
status of DN cd thymocytes in WT cdTCR Tg, Lck
+/2 cdTCR
Tg, and Fyn
+/2 cdTCR Tg mice by measuring their expression
of the Ki-67 Ag, which is a marker of actively cycling cells
[34,35]. We found that the frequency of Ki67
+ DN cd
thymocytes in Lck
+/2 cdTCR Tg mice was significantly higher
than the frequency of Ki67
+ DN cd thymocytes in WT cdTCR
Tg and Fyn
+/2 cdTCR Tg mice (Table 1). These data suggested
thatthenumber of DNcdthymocytes in Lck
+/2 cdTCR Tg mice
does not reflect the number of thymocytes that adopted the cd
fate.
Next, we compared the expression levels of the cdTCR and
CD5 on the surface of DN cd thymocytes from WT cdTCR Tg,
Lck
+/2 cdTCR Tg, and Fyn
+/2 cdTCR Tg mice to gauge the
effects of reducing Lck or Fyn levels on the phenotype of the cells
choosing the cd lineage. When we examined cdTCR and CD5
surface levels on the DN cd thymocytes that were generated in
WT cdTCR Tg, Lck
+/2 cdTCR Tg and Fyn
+/2 cdTCR Tg
mice, we found that DN cd thymocytes in the three genotypes
Figure 3. Effect of reducing Lck or Fyn levels on ab/cd lineage commitment and cd T cell development. A. Dot plots show representative
CD4 versus CD8 staining profiles for WT cdTCR Tg, Lck
+/2 cdTCR Tg, and Fyn
+/2 cdTCR Tg thymocytes. Numbers in the quadrants represent
percentage of cells in each quadrant. The mean thymus cell number 6 SEM for each genotype are displayed above the respective two-color plot.
B. Mean number of DN (DN cdTCR
+; cd lineage) and DP (ab lineage) thymocytes in WT cdTCR Tg, Lck
+/2 cdTCR Tg and Fyn
+/2 cdTCR Tg mice. Data
represent at least 6 mice per genotype. C. Mean number of DN cd T cells in the LNs of WT cdTCR Tg, Lck
+/2 cdTCR Tg and Fyn
+/2 cdTCR Tg mice. Data
represent at least 5 mice per genotype. In B and C, the bars represent mean 6 SEM. *p#0.05, #p#0.001.
doi:10.1371/journal.pone.0008899.g003
Lck, Fyn and cdTCR Signaling
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CD5. Specifically, Lck
+/2 cd thymocytes expressed significantly
higher levels of the cdTCR than WT cd thymocytes, whereas
Fyn
+/2 cd thymocytes expressed significantly lower levels of the
cdTCR than WT cd thymocytes (Fig. 4A). These data suggested
that reducing Lck expression levels weakened cdTCR signal
strength to the extent that immature thymocytes expressing
relatively high levels of the cdTCR adopted the cd fate.
Conversely, reducing Fyn expression levels augmented cdTCR
signal strength to where immature thymocytes expressing
relatively low levels of the cdTCR adopted the cd fate.
To investigate the effects of reducing the levels of Lck or Fyn
on the maturation of cd T cells in the thymus and their
subsequent ability to migrate to t h ep e r i p h e r y ,w ee n u m e r a t e d
DN cd Tc e l l si nt h eL N so fW TcdTCR Tg, Lck
+/2 cdTCR
Tg, and Fyn
+/2 cdTCR Tg mice. Compared to WT cdTCR Tg
mice, we observed a significant decrease in the number of DN
cd T cells in Lck
+/2 cdTCR Tg mice but not in the number of
DN cd T cells in Fyn
+/2 cdTCR Tg mice (Fig. 3C). Consistent
with the lower numbers of peripheral cd T cells in Lck
+/2
cdTCR Tg mice was the finding that there were fewer DN cd T
cells in these mice that expressed CD24, a marker of recent
thymic emigrant cd Tc e l l s[ 3 6 ] ,a n dt h a tt h e r ew e r em o r ec e l l s
that expressed CD44, a marker of activated cells, memory cells,
and/or cells undergoing homeostatic proliferation [36–38]
(Fig. 4B). Moreover, we found that the cdTCR and CD5
surface levels that were noted among the DN cdTCR
+
thymocytes from the three genotypes were maintained on their
respective peripheral cd T cells, with the exception that Lck
+/2
cd T cells expressed significantly lower levels of CD5 than WT
cd Tc e l l s( F i g .4 C ) .T h e r e f o r e ,a l t h o u g hD Ncd thymocytes
Figure 4. Phenotypic analysis of cd lineage cells from Lck
+/2 cdTCR Tg and Fyn
+/2 cdTCR Tg mice. A. Comparison of CD5 and TCRcd
surface levels on DN cd thymocytes from WT cdTCR Tg, Lck
+/2 cdTCR Tg and Fyn
+/2 cdTCR Tg mice. MFIs of CD5 and TCRcd surface levels on DN cd
thymocytes from heterozygous mice are presented as a percentage of the MFIs of CD5 and TCRcd surface levels on DN cd thymocytes from WT
cdTCR Tg mice. Data represent at least 6 mice per genotype. B. Percentage of CD24
+ and CD44
+ cd T cells in WT cdTCR Tg, Lck
+/2 cdTCR Tg and
Fyn
+/2 cdTCR Tg mice. Data represent at least 3 mice per genotype. C. Comparison of CD5 and TCRcd surface levels on DN cd T cells from the LNs of
WT cdTCR Tg, Lck
+/2 cdTCR Tg and Fyn
+/2 cdTCR Tg mice. MFIs of CD5 and TCRcd surface levels on peripheral DN cd T cells from heterozygous mice
are presented as a percentage of the MFIs of CD5 and TCRcd surface levels on peripheral DN cd T cells from WT cdTCR Tg mice. Data represent at
least 5 mice per genotype. In A, B, and C, the bars represent mean 6 SEM. *p#0.05,* * p#0.01, #p#0.001.
doi:10.1371/journal.pone.0008899.g004







WT cdTCR Tg 32.661.2
Lck
+/2 cdTCR Tg 43.766.0**
Fyn
+/2 cdTCR Tg 32.361.8
aKi-67 expression marks cells in late G1 phase through mitosis and is used as
marker of active cell cycling.
**p#0.01.
doi:10.1371/journal.pone.0008899.t001
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+/2 cdTCR Tg mice in numbers
comparable to WT cdTCR Tg mice, these mice had reduced
numbers of mature DN cd T cells. These data indicated that a
reduction in Lck levels but not Fyn levels affects the maturation
and/or survival of thymic cd T cells.
Effect of Reducing Lck or Fyn Levels on cd T Cell Effector
Fate and Function
cd T cell effector fate has been shown to segregate with
expression of specific surface antigens, specifically CD122
+ and/or
CD27
+ cd T cells preferentially produce IFNc [39,40], whereas
IL-23R
+ cd T cells preferentially produce IL-17 [41–43]. Given
these findings, we sought to determine whether reducing the levels
of Lck or Fyn altered the ability of a cd T cell to become an IL-17-
and/or IFNc-producing effector cell. To accomplish this, we chose
to use our cdTCR Tg mouse model as it generates, on the WT
background, 30-fold more DN cd T cells than non-cdTCR Tg
mice [30]. This means that DN cd T cells can be analyzed without
the concern that purification by positive selection using an anti-
TCRcd mAb may crosslink the cdTCR and, in turn, pre-activate
the cd T cell. First, we determined whether there were any
differences in the percentages of cd T cells expressing CD122,
CD27 or IL-23R among WT cdTCR Tg, Lck
+/2 cdTCR Tg, and
Fyn
+/2 cdTCR Tg mice. We found that both Lck
+/2 cdTCR Tg
and Fyn
+/2 cdTCR Tg mice had similar percentages of CD27
+
and CD27
2 cd T cells as WT cdTCR Tg mice, but the
percentages of CD27
+ cells co-expressing CD122
+ in both Lck
+/2
cdTCR Tg and Fyn
+/2 cdTCR Tg mice was reduced compared
to WT cdTCR Tg mice (Fig. 5A). As CD122 expression by cd T
cells is induced when the cdTCR interacts with its ligand in the
Figure 5. Effect of reducing Lck or Fyn levels on cd T cell effector fate and function. A. Dot plots showing representative CD122 versus
CD27 staining profiles for DN cdTCR
+ LN cells from WT cdTCR Tg, Lck
+/2 cdTCR Tg and Fyn
+/2 cdTCR Tg mice. Numbers in the quadrants represent
percentage of cells in that quadrant. The percentage of CD122
+ DN cd T cells is significantly lower in Fyn
+/2 cdTCR Tg mice than in WT cdTCR Tg
mice, p#0.05. Data are representative of at least 6 mice per genotype. B. Quantitative real-time RT-PCR analysis of the relative transcript levels of
IL12RB1 and IL23R in purified peripheral DN cd T cells from WT cdTCR Tg, Lck
+/2 cdTCR Tg and Fyn
+/2 cdTCR Tg mice. Data are normalized to GAPDH
and are presented as fold change over WT cd T cells (set to 1). Bars represent mean 6 SEM. Data represent 3 mice per genotype. C. Comparison of IL-
17 and IFNc production by DN cdTCR
+ LN cells from WT cdTCR Tg, Lck
+/2 cdTCR Tg and Fyn
+/2 cdTCR Tg mice. LN cells from the three genotypes
were in vitro stimulated with 1 or 5 mg/ml of immobilized anti-CD3 mAb or 5 mg/ml of immobilized hamster IgG. 16 h later, cells were harvested and
cytokine production was assayed by i.c. flow cytometric analysis. Dot plots show representative i.c. staining for IFNc versus IL-17 in gated DN cdTCR
+
cells. Numbers in the quadrants represent percentage of cells in that quadrant. Data shown are representative of at least 3 mice per genotype. D.
Comparison of the ability of DN cd T cells from WT cdTCR Tg, Lck
+/2 cdTCR Tg and Fyn
+/2 cdTCR Tg to produce TNFa. Lymph node cells from each
genotype were in vitro stimulated with 5 mg/ml of immobilized anti-CD3 mAb or 5 mg/ml of immobilized hamster IgG. 48 h later, cytokine production
was measured by i.c. flow cytometry. Dot plots show representative staining for i.c. TNFa versus TCRcd in gated DN cdTCR
+ cells. The percentage of
TNFa-producing cd T cells for each genotype is shown. Data are representative of at least 4 mice per genotype.
doi:10.1371/journal.pone.0008899.g005
Lck, Fyn and cdTCR Signaling
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survival of CD122
+ cd T cells is impaired when Lck or Fyn levels
are reduced. To evaluate IL-23R expression among WT, Lck
+/2,
and Fyn
+/2 cd T cells, we performed quantitative real-time RT-
PCR analysis to detect transcription of IL12RB1 and IL23R, which
encode the two subunits of the IL-23R [44]. No significant
differences were noted in the relative amounts of IL12RB1 and
IL23R transcripts among WT, Lck
+/2, and Fyn
+/2 cd T cells
(Fig. 5B), indicating that the selection and/or survival of cd T cells
with the potential to produce IL-17 is not affected when Lck or
Fyn levels are reduced.
Next, we assessed cytokine production by WT, Lck
+/2, and
Fyn
+/2 cd T cells following CD3 crosslinking. Interestingly, we
found that the percentages of WT, Lck
+/2 and Fyn
+/2 cd T cells
producing IFNc at 16 h were equivalent to the percentages of
CD122
+ CD27
+ cd T cells in each mouse (Fig. 5A and C). It is also
important to note that the level of IFNc production, as measured




cells than in WT IFNc
+ cd T cells (Fig. 5C and data not shown).
Moreover, when we compared the ability of WT, Lck
+/2 and
Fyn
+/2 cd T cells to differentiate into IL-17-producing cells at
16 h, we detected considerably fewer Fyn
+/2 IL-17
+ cd T cells
than Lck
+/2 or WT IL-17
+ cd T cells (Fig. 5C). Taken together,
these data indicated that reducing the levels of Fyn impacts the
function of cd T cells that have the potential to become either IL-
17- or IFNc-producing effector cells, while reducing the levels of
Lck only impacts the function of cd T cells that have the potential
to become IFNc-producing effector cells.
Because Lck
+/2 and Fyn
+/2 cd T cells do not efficiently
produce IFNc, it was of interest to determine whether reducing
Lck or Fyn levels also affected the ability of cd T cells to produce
other cytokines. To test this, we evaluated TNFa production by cd
T cells from Lck
+/2 cdTCR Tg and Fyn
+/2 cdTCR Tg mice,
since cd T cells, including those that produce IFNc, have been
shown to produce this cytokine [40]. As shown in Fig. 5D, we
found that more cd T cells from Lck
+/2 cdTCR Tg and Fyn
+/2
cdTCR Tg mice than from WT cdTCR Tg mice were producing
TNFa. These data indicated that reducing Lck or Fyn levels does
not impair the ability of cd T cells to produce TNFa and suggested
that the TCR signals required to activate the genetic program for
IFNc production are different than those for TNFa production.
Discussion
Since SFKs have both positive and negative roles in receptor
signaling, it has been postulated that these kinases function more
like rheostats than on/off switches [45]. Our data support this
idea, as changes in the cellular levels of Lck or Fyn at different
stages in the life of a cd lineage cell affected the strength of the
cdTCR signaling response and, in turn, affected ab/cd line-
age commitment, cd T cell maturation and cd T effector cell
differentiation.
The expression levels of Lck and Fyn change during T cell
development and maturation. Immature thymocytes (i.e., DN2
thymocytes), which have the potential to become either ab or cd
lineage cells [26,27], expressed relatively high levels of both Lck
and Fyn. In thymic cd lineage cells, these high levels of Lck and
Fyn were maintained and, not until the cd lineage cells were
exported from the thymus, did their Lck and Fyn expression levels
decrease. However, in immature ab lineage cells, Lck and Fyn
expression levels dramatically declined and, at the DP stage, their
levels of Lck and Fyn were extremely low. The low SFK
expression in DP thymocytes has also been reported by Olszowy
et al. [46], who used quantitative Western blot analysis to measure
Lck and Fyn protein levels in thymocyte subsets. Interestingly, Lck
and Fyn levels were increased in TCR
hi DP (data not shown) and
SP thymocytes compared to DP thymocytes, suggesting that
positive selection upregulated both Lck and Fyn expression. It is
important to note that mature SP thymocytes, after leaving the
thymus, downregulated Lck and Fyn expression levels, but not to
the levels observed for DP thymocytes nor to the extent observed
between thymic and peripheral cd T cells.
To investigate the importance of the quantitative difference in
Lck and Fyn expression levels between thymic and peripheral cd T
cells, we used Lck
+/2 and Fyn
+/2 mice to study the effect of
reducing Lck or Fyn expression levels on cd T cell development
and function. We chose to reduce, as opposed to eliminate, Lck
and Fyn expression levels to prevent any compensatory action that
one SFK may exhibit in the absence of the other. Although Fyn
levels were reduced by 50% in ab lineage cells from Fyn
+/2 mice,
they were only reduced by 40% in cd lineage cells from the same
mice. There are two possible explanations, which are not mutually
exclusive, for why Fyn levels were not reduced to the expected
50% in cd lineage cells from Fyn
+/2 mice. First, the relatively high
levels of Fyn in Fyn
+/2 cd thymocytes may be a result of selection,
where only cells with high levels of Fyn survive and continue to
mature. The second possibility is that the high Fyn levels in cd
lineage cells reflect high Fyn levels in a precursor population, such
as DN2 thymocytes, which have the developmental potential to
give rise to ab and cd lineage cells [26,27]. Indeed, we found that
Fyn expression was only reduced by ,15% in DN2 thymocytes
from Fyn
+/2 mice. Therefore, even though we cannot rule out
selection of cd thymocytes with high levels of Fyn, it is conceivable
that the relatively high levels of Fyn in cd thymocytes from Fyn
+/2
mice may be a direct result of the high levels of Fyn in Fyn
+/2
DN2 thymocytes.
The high level of Fyn in thymic precursors highlights the
importance of Fyn activity during an early stage of T cell
development. As surface TCR complexes are not expressed at this
stage, it is possible that Fyn is required for signaling through other
receptors. One such receptor may be the IL-7 receptor (IL-7R), as
Fyn has been shown to be recruited to this receptor [47,48]. Given
this association and that DN2 thymocytes require IL-7R
expression and signaling for their survival and proliferation
[49–53], it is possible that relatively high levels of Fyn are
required for proper IL-7R signaling at this stage.
The first stage in T cell development where we observed
regulation of cdTCR signal strength by Lck and Fyn is during
ab/cd lineage commitment. We and others have previously
demonstrated that TCR signal strength influences the ab/cd
lineage decision, with a strong signal favoring cd lineage
commitment and a weak signal favoring ab lineage commitment
[29,33,54]. By fixing the specificity of the cdTCR, we were able
to detect changes in the cdTCR signal response that were not
apparent with a polyclonal cdTCR repertoire. Reducing the
expression of Lck weakened cdTCR signal strength and resulted in
a striking increase in the percentage and number of DP
thymocytes in Lck
+/2 cdTCR Tg mice compared to WT cdTCR
Tg mice. Moreover, weakening of the cdTCR signal was
confirmed by the finding that DN cd thymocytes from Lck
+/2
cdTCR Tg mice expressed higher levels of the cdTCR than WT
DN cd thymocytes. Together, these results indicated that relatively
high levels of Lck are required to achieve the appropriate TCR
signal response to support the cd lineage choice. Conversely,
reducing Fyn expression levels strengthened the cdTCR signaling
response, as evidenced by the decrease, albeit not significant, in
the number of DP thymocytes and the significant decrease in
cdTCR surface expression on DN cd thymocytes from Fyn
+/2
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which cd T cell fate was favored over ab T cell fate when cdTCR
signal strength was augmented [29], reducing Fyn expression had
modest effects on the generation of ab and cd lineage cells. This
difference may be attributed to the fact that Fyn expression was
reduced by 35% in cd thymocytes from Fyn
+/2 cdTCR Tg mice
(data not shown), suggesting that immature DN thymocytes
expressing low levels of Fyn were unable to survive and develop
into ab or cd lineage cells.
Our data also demonstrated that the alterations in cdTCR
signal strength by reducing Lck or Fyn expression levels affected
cd T cell maturation in the thymus. When cdTCR signal strength
was weakened by reducing Lck levels, there was a significant
decrease in the number of DN cd T cells in LNs despite normal
numbers of cd lineage cells present in the thymus. In support of a
maturation defect, the frequency of recent thymic emigrants
(CD24
+ DN cdTCR
+) was reduced in the LNs of Lck
+/2 cdTCR
Tg mice. Because of the reduction in thymic output, Lck
+/2 cd T
cells seemingly underwent homeostatic proliferation in the
periphery, evidenced by the increased frequency of cd T cells
with an activated/memory phenotype (CD44
+ DN cdTCR
+). On
the other hand, strengthening the cdTCR signal response by
reducing Fyn levels had little effect on thymic maturation. These
data not only demonstrate that signaling by the cdTCR is required
following cd lineage commitment for cd thymocyte maturation,
but also indicate that the cellular levels of Lck in cd thymocytes
regulate the cdTCR signaling response at this developmental
stage.
Unlike ab thymocytes, cd thymocytes do not need to encounter
Ag to mature and emigrate to the periphery [39,55]. However, a
recent study demonstrates that Ag encounter in the thymus by cd
T cells controls their effector fate, with Ag-experienced cd T cells
expressing CD122 and preferentially producing IFNc and Ag-
naı ¨ve cd T cells lacking CD122 expression and preferentially
producing IL-17 [39]. In addition to CD122 expression, cd T cell
effector fate has been shown to segregate with CD27 expression, in
that CD27
+ cd T cells produce IFNc and CD27
2 cd T cells
produce IL-17 [40]. We found that either weakening or
augmenting the cdTCR signal response had an impact on the
generation and/or survival of CD122
+ CD27
+ cd T cells but not
on the generation and/or survival of CD122
2 CD27
+ cd T cells.
Unfortunately, we do not know whether the defect lies in CD122
+
cd T cell selection, survival or both, as very few (,0.5%) CD122
+
cd T cells are detected in the thymus of WT cdTCR Tg, Lck
+/2
cdTCR Tg, and Fyn
+/2 cdTCR Tg mice (data not shown). Since
Vc6/Vd1
+ cd T cells are normally generated in the fetal thymus
[28], the paucity of CD122
+ cd thymocytes in WT cdTCR Tg
mice may be due to decreased or negligible expression of the
ligand for the Vc6/Vd1 cdTCR in the adult thymus. Nonetheless,
we propose that weakening the cdTCR signal results in the
generation of fewer CD122+ cd thymocytes following Ag
encounter in the thymus. However, due to homeostatic prolifer-
ation in the periphery, the size of the CD122
+ cd T cell pool is
consequently increased. When the cdTCR signal is augmented, on
the other hand, Ag encounter in the thymus may lead to negative
selection and, in turn, fewer cd thymocytes and peripheral cd T
cells expressing CD122. Surprisingly, in regards to cd T cells with
the potential to produce IL-17, we found that neither weakening
nor augmenting cdTCR signal strength had an impact on their
generation and/or survival, based on the comparable expression
of IL23R and IL12RB1 in cd T cells from the three genotypes.
These results indicate that cd T cells destined to become IL-17
producers, unlike those destined to become IFNc producers,
are not dependent on Lck- or Fyn-mediated signaling for their
generation and/or survival, and suggest that the choice to become
an IFNc effector versus an IL-17 effector is not a binary fate
decision.
Consistent with their being multiple cd effector fates is our
finding that, following TCR stimulation, 10% of WT cd T
cells produce IFNc, 5% produce IL-17 and 30% produce TNFa
[a third of these also produce IFNc, while none produce IL-17
(data not shown)]. Interestingly, the frequency of CD122
+ cd T
cells but not CD27
+ cd T cells was found to be an indicator of
IFNc production by cd T cells, regardless of whether the
stimulated cd T cells were from WT cdTCR Tg, Lck
+/2 cdTCR
Tg, and Fyn
+/2 cdTCR Tg mice. While our finding is consistent
with the findings of the recent study demonstrating that CD122
expression correlates with IFNc production, it is not consistent
with those of the other study demonstrating that CD27 expression
correlates with IFNc production. An explanation for the difference
in results may be how, in each study, cd T cells were stimulated. In
our study, as well as that of Jensen et al. [38], cd T cells were
stimulated by crosslinking the TCR with anti-CD3 or anti-TCRd
mAbs. However, in the study of Ribot et al. [39], cd T cells were
first activated and expanded in the presence of anti-CD3 mAb and
IL-2 for four days prior to re-stimulation with the phorbol ester,
phorbol 12-myristate 13-acetate, and ionomycin. These data,
taken together, suggest that CD122
+ cd T cells rapidly produce
IFNc following TCR activation, whereas CD27
+ cd T cells
require multiple days post TCR activation to differentiate into
IFNc-producing cells. Notably, both weakening and augmenting
cdTCR signal strength affected the proficiency by which cd T cells
produced IFNc but not TNFa. This finding indicates that cdTCR
signal strength regulates the quality of the cytokine effector
response of stimulated cd T cells. Moreover, having both weak
and strong TCR signals leading to a similar outcome is not novel
in T cell biology, as for example it well known that DP thymocytes
that receive TCR signals that are too weak or too strong undergo
apoptosis [reviewed in 56].
In summary, we have demonstrated that the cellular levels of
Lck or Fyn regulate the strength of the cdTCR signaling response.
Specifically, we found that reducing Lck levels, thereby weakening
cdTCR signal strength, had profound effects on ab/cd lineage
commitment, cd thymocyte maturation, and the generation of
IFNc-producing effectors. In contrast, when Fyn levels were
reduced, thus augmenting cdTCR signal strength, we observed
defects in the generation of both IL-17- and IFNc-producing
effectors. Thus, this study has revealed that a relatively strong
cdTCR signaling response is required following cd lineage




All research involving animals has been conducted according to
the relevant national and international guidelines with respect to
husbandry, experimentation and welfare. Mouse protocols were
approved by the SUNY Upstate Medical University Committee
on the Humane Use of Animals.
Mice





2/2) mice were originally purchased
from The Jackson Laboratory (Bar Harbor, ME, USA). C57BL/6-
Vc6/Vd1 cdTCR Tg mice (cdTCR Tg; line 134) [28] were kindly
provided by P.E. Love (NICHD, Bethesda, MD, USA). Mice
used in this study were bred and maintained in the Department of
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University in accordance with the specifications of the Association
for Assessment and Accreditation of Laboratory Animal Care. All
mice were sacrificed at 6–8 weeks of age.
Antibodies
Monoclonal antibodies (mAbs) used for flow cytometric analysis,
cd T cell separation and cd T cell stimulation included anti-CD3
(145-2C11), anti-CD4 (RM4-5), anti-CD5 (53-7.3), anti-CD8a
(53-6.7), anti-CD8b (53-5.8), anti-TCRcd (UC7-13D5), anti-
TCRb (H57-597), anti-CD11b (M1/70), anti-CD16/CD32
(2.4G2), anti-CD19 (6D5), anti-IA
b (AF6-120.1), anti-CD24
(M1/69), anti-CD27 (LG.7F9), anti-CD44 (IM7), anti-CD122
(5H4), anti-NK1.1 (PK136), and anti-Ly6-G/Ly6-C (RB6-8C5),
which were purchased from BD Pharmingen (San Jose, CA, USA),
BioLegend (San Diego, CA, USA) or eBioscience (San Diego, CA,
USA). mAbs used for intracellular (i.c.) flow cytometric analysis
were Ki-67 (B56; BD Pharmingen), anti-Lck (3A5; Upstate
Biotechnology, Billerica, MA, USA), anti-Fyn (FYN-59; BioLe-
gend), anti-mouse IgG2b (R12-3; BD Pharmingen), anti-IL-17A
(TC11-18H10.1; BioLegend), anti-TNFa (MP6-XT22; BioLe-
gend), and anti-IFNc (XMG1.2; BD Pharmingen).
In Vitro Stimulation of cd T Cells
3610
6 lymph node (LN) cells from WT, Lck
+/2 and Fyn
+/2
cdTCR Tg mice were resuspended in RPMI 1640 supplemented
with non-essential amino acids, L-glutamine, HEPES, sodium
pyruvate, and penicillin/streptomycin (all from Invitrogen,
Carlsbad, CA, USA) in addition to 10% FBS (Mediatech, Inc.,
Manassas, VA, USA), plated onto 1 or 5 mg/ml of immobilized
anti-CD3 mAb or 5 mg/ml of immobilized hamster isotype
control, and then cultured for 16 or 48 h at 37uC. 5 h prior to
fixation, permeabilization, and i.c. staining with mAbs against IL-
17A, TNFa and/or IFNc, cells were treated with Brefeldin A and
Monensin (eBioscience).
Flow Cytometry
Flow cytometric analysis for surface antigens was performed by
pre-incubating cells with the anti-CD16/CD32 mAb for at least
10 min to block non-specific binding of immunoglobulins to Fc
receptors followed by staining with fluorochrome-conjugated Abs
against the various surface antigens. I.c. staining for Ki-67 was
performed according to the manufacturer’s instructions (BD
Pharmingen). I.c. staining for Lck and Fyn in addition to IL-
17A, TNFa and IFNc was performed by first fixing cells in a final
concentration of 1.5% formaldehyde for 10 min at 37uC. Fixed
cells were then stained for surface antigens, permeabilized with
Perm/Wash Buffer (BD Pharmingen) for 20 min at 4uC, and then
stained with mAbs against the appropriate proteins. The mAbs
specific for IL-17A, TNFa and IFNc were directly conjugated to a
fluorochrome, while FITC-conjugated anti-mouse IgG2b Ab was
used as a secondary reagent to detect the anti-Lck mAb or the
anti-Fyn mAb. For all experiments, 0.1–2610
6 cells were collected
on a LSR II using FACSDiva software (BD Immunocytometry
Systems, San Jose, CA, USA) and analyzed using FlowJo software
(Tree Star Inc., Ashland, OR, USA). Dead cells were excluded
from analysis based on forward and side scatter profiles.
Cell Separation
DN cd T cells were purified by negative selection from the
LNs of WT cdTCR Tg, Lck
+/2 cdTCR Tg and Fyn
+/2 cdTCR
Tg mice using the MACS magnetic bead separation system
(Miltenyi Biotec, Auburn, CA, USA). LN cells were stained for
10 min at 4uCw i t hap a n e lo fF I T C - l a beled mAbs containing
anti-CD19, anti-TCRb, anti-CD4, anti-CD8, anti-IA
b and anti-
DX5 mAbs. Cells were washed, incubated with anti-FITC
MACS beads for 15 min at 4uC, and then separated on an
autoMACS cell separator, according to manufacturer’s direc-
tions. The purity of the resulting DN cd T cell populations were
typically $99%.
RT-PCR Analysis
RNA was extracted from purified DN cd T cells using the
Qiagen RNeasy kit (Valencia, CA, USA). cDNA was then
synthesized using Invitrogen’s SuperScriptH First-Strand Synthesis
System. Quantitative real-time RT-PCR analysis was performed
using a Bio-Rad iQ
TM5 Real-time PCR machine (Hercules, CA,
USA) according to manufacturer’s directions. All of the primer sets
for the quantitative real-time RT-PCR analysis, which included
GAPDH, IL12RB1, and IL23R, along with the SYBR Green PCR
Master Mix were purchased from SABiosciences (Frederick, MD,
USA).
Statistical Analysis
Data are presented as mean 6 SEM. Student’s t-test was used
for all statistical comparisons (Graph Pad Prism or Microsoft Excel
software) except for the one evaluating Fyn levels in ab lineage
cells, cd lineage cells and DN2 thymocytes from Fyn
+/2 mice, in
which a x
2 test (Microsoft Excel software) was used. p values less
than or equal to 0.05 were considered statistically significant.
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